PDB35 Evaluation of Cost Offset Associated with Tolvaptan Usage among Hyponatremic Siadh Patients in the United States, Based on the Salt-1 and Salt-2 Trials
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.956
https://www.valueinhealthjournal.com/article/S1098-3015(12)01021-2/fulltext
Title :
PDB35 Evaluation of Cost Offset Associated with Tolvaptan Usage among Hyponatremic Siadh Patients in the United States, Based on the Salt-1 and Salt-2 Trials
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01021-2&doi=10.1016/j.jval.2012.03.956
First page :
A176
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
447